TAKECAB Granted Approval for the Treatment of Acid-related Diseases in Japan

TAKECAB Granted Approval for the Treatment of Acid-related Diseases in Japan
In Japan, a new drug called TAKECAB® (Vonoprazan Fumarate) for the treatment of acid-related diseases was granted approval from the Japanese Ministry of Health, Labour and Welfare. The companies Takeda Pharmaceutical Company Limited and Otsuka Pharmaceutical Company, Limited signed an agreement in March 2014 to co-promote the drug in Japan. Based on the agreement, Takeda

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *